All News #Library
Biotech
Pharmazz Begins Phase 3 Trial of Sovateltide for Ischemic Stroke
29 Jul 2025 //
GLOBENEWSWIRE
A Special Protocol Assessment Agreement Reached with FDA for Ph 3 of Sovateltide
02 Oct 2023 //
GLOBENEWSWIRE
Pharmazz, Inc. Announces Marketing Approval of Sovateltide in India
31 May 2023 //
GLOBENEWSWIRE
Pharmazz Announces US FDA Clearance for a PhIII Clinical Trial of Sovateltide
13 Feb 2023 //
PR NEWSWIRE
Clinical PIII Trial Results Demonstrating Sovateltide`s Efficacy
10 Feb 2023 //
PR NEWSWIRE

Market Place
Sourcing Support